GeneDx Holdings WGS Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 69.6%-0.2pp | 69.7%+0.1pp | 69.6%+2.5pp | 67.2%+1.9pp | 65.3%+1.6pp | |
| Operating margin | -14.9%-11.8pp | -3.1%— | —— | —— | —— | |
| Net margin | -17.6%-12.7pp | -4.9%— | —— | —— | —— | |
| Returns | ||||||
| Return on equity | -30.4%-22.8pp | -7.6%— | —— | —— | —— | |
| Return on invested capital | -28.3%-23.9pp | -4.4%— | —— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 0.9×0.0× | 0.9×0.0× | 0.9×0.0× | 0.8×+0.1× | 0.8×+0.1× | |
| Liquidity | ||||||
| Current ratio | 3.1×+0.6× | 2.5×-0.2× | 2.7×-0.2× | 2.9×-0.4× | 3.2×-0.4× | |
| Leverage | ||||||
| Debt-to-equity | 0.4×0.0× | 0.4×+0.2× | 0.2×0.0× | 0.2×0.0× | 0.2×-0.3× | |
| Per Share | ||||||
| Book value per share | $8.66-19.5% | $10.76+6.0% | $10.15+9.0% | $9.31+1.9% | $9.14+0.3% | |
| Valuation | ||||||
| Market capitalization | $1.88B-50.0% | $3.76B+21.5% | $3.09B+19.3% | $2.59B+4.3% | $2.49B+17.7% | |
| Price / sales | 4.2×-4.5× | 8.8×+1.1× | 7.7×+0.5× | 7.2×-0.4× | 7.5×+0.6× | |
| Price / book | 7.4×-4.8× | 12.2×+1.6× | 10.6×+1.2× | 9.4×-0.3× | 9.7×+1.0× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are GeneDx Holdings's profit margins?
- GeneDx Holdings (WGS) runs a 69.6% gross margin and a -14.9% operating margin, with a -17.6% net margin.
- Where do GeneDx Holdings's ratios come from?
- Every ratio is computed from GeneDx Holdings's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
